Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 12 Nov 2024 | 5 Nov 2024 |
To consider and approve the unaudited financial results for the period ended September 30, 2024 and other business matters Aatmaj Healthcare Limited has informed the Exchange regarding Board meeting held on November 12, 2024 has approved Standalone Un-Audited Financial Results of the Company for the half year ended September 30, 2024 along with Limited Review Report of the Auditors thereon (As Per NSE Announcement Dated on: 12/11/2024) | ||
Board Meeting | 25 May 2024 | 16 May 2024 |
To consider and approve the Standalone Audited Financial Results for the half year and year ended March 31, 2024, declaration of dividend, if any and other business matters. Aatmaj Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on May 25, 2024, approved and taken on record the Standalone Audited Financial Statements of the Company for the half year and Year ended on March 31, 2024 along with Auditors Report thereon and recommended Final Dividend of 0.05 per equity share (As per NSE Announcement Dated on 25/05/2024) Aatmaj Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. (As Per NSE Announcement Dated on 31/05/2024) |
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.